4- [(1H - imidazol - 4 - YL) methyl] benzamidines and benzylamidines: novel antagonists of the histamine H3 receptor
- 1 August 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (16) , 2263-2268
- https://doi.org/10.1016/s0960-894x(98)00399-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Trans-4-methyl-3-imidazoyl pyrrolidine as a potent, highly selective histamine H3 receptor agonist in vivoBioorganic & Medicinal Chemistry Letters, 1998
- Novel Histamine H3 Receptor Antagonists: Synthesis and Evaluation of Formamidine and S-Methylisothiourea Derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1997
- Molecular pharmacological aspects of histamine receptorsPharmacology & Therapeutics, 1995
- Histamine H3 receptors modulate the release of [3H]‐acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypesBritish Journal of Pharmacology, 1992
- Two novel, potent and selective histamine H3 receptor agonistsBioorganic & Medicinal Chemistry Letters, 1992
- Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortexNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- Highly potent and selective ligands for histamine H3-receptorsNature, 1987
- (Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonistsJournal of Medicinal Chemistry, 1984
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptorNature, 1983